# ANSTO (Australian Nuclear Science and Technology Organisation)

Source: https://onco.cc/companies/ansto/  
OnCo record `ansto` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

ANSTO runs the OPAL research reactor near Sydney and a molybdenum-99 plant that supplies Australia's nuclear medicine and exports, and produces lutetium-177 for radioligand therapy.

## Summary

The Australian Nuclear Science and Technology Organisation operates the OPAL reactor at Lucas Heights, commissioned in 2007, and the ANSTO Nuclear Medicine molybdenum-99 processing plant opened in 2019 to serve domestic technetium generators and export. It also produces non-carrier-added lutetium-177 and other isotopes and runs a national radiopharmaceutical distribution operation. Outages at the processing plant in its first years produced domestic shortages and imports from other processors.

## Fields

- Kind: Company
- Last checked: 2026-09-17
- Also known as: ANSTO Nuclear Medicine
- Tags: manufacturing-wave
- HQ: Lucas Heights, Sydney
- Type: radiopharma
- Website: https://www.ansto.gov.au

## Sources

- Official website: https://www.ansto.gov.au

## Connected records

- technologies: [Radiopharmacy and cyclotron networks](https://onco.cc/technologies/radiopharmacy-network/), [Research reactors for medical isotopes (Mo-99, Lu-177, I-131)](https://onco.cc/technologies/research-reactor-isotope-production/), [Therapeutic isotope supply chain (Mo-99, Lu-177, Ac-225)](https://onco.cc/technologies/therapy-isotope-supply-chain/)

---
JSON: https://onco.cc/api/v1/entities/ansto.json